CreatorsPublishersAdvertisers
View more in
Cancer

Low-Dose Chemotherapy With Immunotherapy Shows Efficacy in UC

targetedonc.com
 2021-08-03

Cover picture for the articleIn an interview with Targeted Oncology™, Rhonda L. Bitting, MD, discussed the efficacy results and key takeaways of a study investigating low-dose paclitaxel plus pembrolizumab in patients with platinum-refractory UC. While single-agent checkpoint inhibitors can be an effective treatment option for some platinum-refractory urothelial carcinoma (UC) patients, additional therapies are...

www.targetedonc.com

Comments / 0

Comments / 0